APO Research
Talk to an analyst

APO RESEARCH · REPORT

Saphris (Asenapine)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Saphris (Asenapine) Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchSaphris (Asenapine) Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Saphris (Asenapine) Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Saphris (Asenapine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Saphris (Asenapine) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Saphris (Asenapine) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Saphris (Asenapine) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Saphris (Asenapine) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Saphris (Asenapine) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Saphris (Asenapine) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Saphris (Asenapine) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Saphris (Asenapine) include Merck & Co., Inc., Allergan plc (AbbVie Inc.) and Actavis Generics (Teva), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Saphris (Asenapine), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Saphris (Asenapine), also provides the sales of main regions and countries. Of the upcoming market potential for Saphris (Asenapine), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Saphris (Asenapine) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Saphris (Asenapine) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Saphris (Asenapine) sales, projected growth trends, production technology, application and end-user industry.

Saphris (Asenapine) Segment by Company

Merck & Co., Inc.

Allergan plc (AbbVie Inc.)

Actavis Generics (Teva)

Saphris (Asenapine) Segment by Type

5 mg

10 mg

Saphris (Asenapine) Segment by Application

Schizophrenia

Acute Mania

Others

Saphris (Asenapine) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Saphris (Asenapine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Saphris (Asenapine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Saphris (Asenapine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Saphris (Asenapine) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Saphris (Asenapine) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Saphris (Asenapine) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Saphris (Asenapine) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5 mg Major Manufacturers Table 3. 10 mg Major Manufacturers Table 4. Global Saphris (Asenapine) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Schizophrenia Major Manufacturers Table 6. Acute Mania Major Manufacturers Table 7. Others Major Manufacturers Table 8. Saphris (Asenapine) Industry Trends Table 9. Saphris (Asenapine) Industry Drivers Table 10. Saphris (Asenapine) Industry Opportunities and Challenges Table 11. Saphris (Asenapine) Industry Restraints Table 12. Global Saphris (Asenapine) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Saphris (Asenapine) Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Saphris (Asenapine) Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Saphris (Asenapine) Revenue Market Share by Region (2021-2026) Table 16. Global Saphris (Asenapine) Revenue Market Share by Region (2027-2032) Table 17. Global Saphris (Asenapine) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Saphris (Asenapine) Sales by Region (2021-2026) & (k units) Table 19. Global Saphris (Asenapine) Sales by Region (2027-2032) & (k units) Table 20. Global Saphris (Asenapine) Sales Market Share by Region (2021-2026) Table 21. Global Saphris (Asenapine) Sales Market Share by Region (2027-2032) Table 22. Global Saphris (Asenapine) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Saphris (Asenapine) Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Saphris (Asenapine) Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Saphris (Asenapine) Sales Market Share by Manufacturers (2021-2026) Table 26. Global Saphris (Asenapine) Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Saphris (Asenapine) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Saphris (Asenapine) Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Saphris (Asenapine) Manufacturers, Product Type & Application Table 30. Global Saphris (Asenapine) Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Saphris (Asenapine) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Saphris (Asenapine) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Saphris (Asenapine) Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Saphris (Asenapine) Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Saphris (Asenapine) Revenue Market Share by Type (2021-2026) Table 37. Global Saphris (Asenapine) Revenue Market Share by Type (2027-2032) Table 38. Global Saphris (Asenapine) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Saphris (Asenapine) Sales by Type (2021-2026) & (k units) Table 40. Global Saphris (Asenapine) Sales by Type (2027-2032) & (k units) Table 41. Global Saphris (Asenapine) Sales Market Share by Type (2021-2026) Table 42. Global Saphris (Asenapine) Sales Market Share by Type (2027-2032) Table 43. Global Saphris (Asenapine) Price by Type (2021-2026) & (US$/unit) Table 44. Global Saphris (Asenapine) Price by Type (2027-2032) & (US$/unit) Table 45. Global Saphris (Asenapine) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Saphris (Asenapine) Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Saphris (Asenapine) Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Saphris (Asenapine) Revenue Market Share by Application (2021-2026) Table 49. Global Saphris (Asenapine) Revenue Market Share by Application (2027-2032) Table 50. Global Saphris (Asenapine) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Saphris (Asenapine) Sales by Application (2021-2026) & (k units) Table 52. Global Saphris (Asenapine) Sales by Application (2027-2032) & (k units) Table 53. Global Saphris (Asenapine) Sales Market Share by Application (2021-2026) Table 54. Global Saphris (Asenapine) Sales Market Share by Application (2027-2032) Table 55. Global Saphris (Asenapine) Price by Application (2021-2026) & (US$/unit) Table 56. Global Saphris (Asenapine) Price by Application (2027-2032) & (US$/unit) Table 57. Merck & Co., Inc. Company Information Table 58. Merck & Co., Inc. Business Overview Table 59. Merck & Co., Inc. Saphris (Asenapine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Merck & Co., Inc. Saphris (Asenapine) Product Portfolio Table 61. Merck & Co., Inc. Recent Development Table 62. Allergan plc (AbbVie Inc.) Company Information Table 63. Allergan plc (AbbVie Inc.) Business Overview Table 64. Allergan plc (AbbVie Inc.) Saphris (Asenapine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Allergan plc (AbbVie Inc.) Saphris (Asenapine) Product Portfolio Table 66. Allergan plc (AbbVie Inc.) Recent Development Table 67. Actavis Generics (Teva) Company Information Table 68. Actavis Generics (Teva) Business Overview Table 69. Actavis Generics (Teva) Saphris (Asenapine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Actavis Generics (Teva) Saphris (Asenapine) Product Portfolio Table 71. Actavis Generics (Teva) Recent Development Table 72. North America Saphris (Asenapine) Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Saphris (Asenapine) Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Saphris (Asenapine) Sales by Type (2021-2026) & (k units) Table 75. North America Saphris (Asenapine) Sales by Type (2027-2032) & (k units) Table 76. North America Saphris (Asenapine) Sales Price by Type (2021-2026) & (US$/unit) Table 77. North America Saphris (Asenapine) Sales Price by Type (2027-2032) & (US$/unit) Table 78. North America Saphris (Asenapine) Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Saphris (Asenapine) Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Saphris (Asenapine) Sales by Application (2021-2026) & (k units) Table 81. North America Saphris (Asenapine) Sales by Application (2027-2032) & (k units) Table 82. North America Saphris (Asenapine) Sales Price by Application (2021-2026) & (US$/unit) Table 83. North America Saphris (Asenapine) Sales Price by Application (2027-2032) & (US$/unit) Table 84. North America Saphris (Asenapine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Saphris (Asenapine) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Saphris (Asenapine) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Saphris (Asenapine) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 88. North America Saphris (Asenapine) Sales by Country (2021-2026) & (k units) Table 89. North America Saphris (Asenapine) Sales by Country (2027-2032) & (k units) Table 90. North America Saphris (Asenapine) Sales Price by Country (2021-2026) & (US$/unit) Table 91. North America Saphris (Asenapine) Sales Price by Country (2027-2032) & (US$/unit) Table 92. United States Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 93. Canada Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 94. Mexico Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 95. Europe Saphris (Asenapine) Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Saphris (Asenapine) Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Saphris (Asenapine) Sales by Type (2021-2026) & (k units) Table 98. Europe Saphris (Asenapine) Sales by Type (2027-2032) & (k units) Table 99. Europe Saphris (Asenapine) Sales Price by Type (2021-2026) & (US$/unit) Table 100. Europe Saphris (Asenapine) Sales Price by Type (2027-2032) & (US$/unit) Table 101. Europe Saphris (Asenapine) Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Saphris (Asenapine) Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Saphris (Asenapine) Sales by Application (2021-2026) & (k units) Table 104. Europe Saphris (Asenapine) Sales by Application (2027-2032) & (k units) Table 105. Europe Saphris (Asenapine) Sales Price by Application (2021-2026) & (US$/unit) Table 106. Europe Saphris (Asenapine) Sales Price by Application (2027-2032) & (US$/unit) Table 107. Europe Saphris (Asenapine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Saphris (Asenapine) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe Saphris (Asenapine) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe Saphris (Asenapine) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 111. Europe Saphris (Asenapine) Sales by Country (2021-2026) & (k units) Table 112. Europe Saphris (Asenapine) Sales by Country (2027-2032) & (k units) Table 113. Europe Saphris (Asenapine) Sales Price by Country (2021-2026) & (US$/unit) Table 114. Europe Saphris (Asenapine) Sales Price by Country (2027-2032) & (US$/unit) Table 115. Germany Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 116. France Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 117. U.K. Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 118. Italy Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 119. Russia Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 120. Spain Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 121. Netherlands Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 122. Switzerland Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 123. Sweden Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 124. Poland Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 125. China Saphris (Asenapine) Revenue by Type (2021-2026) & (US$ Million) Table 126. China Saphris (Asenapine) Revenue by Type (2027-2032) & (US$ Million) Table 127. China Saphris (Asenapine) Sales by Type (2021-2026) & (k units) Table 128. China Saphris (Asenapine) Sales by Type (2027-2032) & (k units) Table 129. China Saphris (Asenapine) Sales Price by Type (2021-2026) & (US$/unit) Table 130. China Saphris (Asenapine) Sales Price by Type (2027-2032) & (US$/unit) Table 131. China Saphris (Asenapine) Revenue by Application (2021-2026) & (US$ Million) Table 132. China Saphris (Asenapine) Revenue by Application (2027-2032) & (US$ Million) Table 133. China Saphris (Asenapine) Sales by Application (2021-2026) & (k units) Table 134. China Saphris (Asenapine) Sales by Application (2027-2032) & (k units) Table 135. China Saphris (Asenapine) Sales Price by Application (2021-2026) & (US$/unit) Table 136. China Saphris (Asenapine) Sales Price by Application (2027-2032) & (US$/unit) Table 137. Asia Saphris (Asenapine) Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Saphris (Asenapine) Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Saphris (Asenapine) Sales by Type (2021-2026) & (k units) Table 140. Asia Saphris (Asenapine) Sales by Type (2027-2032) & (k units) Table 141. Asia Saphris (Asenapine) Sales Price by Type (2021-2026) & (US$/unit) Table 142. Asia Saphris (Asenapine) Sales Price by Type (2027-2032) & (US$/unit) Table 143. Asia Saphris (Asenapine) Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Saphris (Asenapine) Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Saphris (Asenapine) Sales by Application (2021-2026) & (k units) Table 146. Asia Saphris (Asenapine) Sales by Application (2027-2032) & (k units) Table 147. Asia Saphris (Asenapine) Sales Price by Application (2021-2026) & (US$/unit) Table 148. Asia Saphris (Asenapine) Sales Price by Application (2027-2032) & (US$/unit) Table 149. Asia Saphris (Asenapine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Saphris (Asenapine) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Asia Saphris (Asenapine) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Asia Saphris (Asenapine) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 153. Asia Saphris (Asenapine) Sales by Country (2021-2026) & (k units) Table 154. Asia Saphris (Asenapine) Sales by Country (2027-2032) & (k units) Table 155. Asia Saphris (Asenapine) Sales Price by Country (2021-2026) & (US$/unit) Table 156. Asia Saphris (Asenapine) Sales Price by Country (2027-2032) & (US$/unit) Table 157. Japan Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 158. South Korea Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 159. India Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 160. Australia Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 161. Taiwan Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 162. Southeast Asia Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 163. SAMEA Saphris (Asenapine) Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Saphris (Asenapine) Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Saphris (Asenapine) Sales by Type (2021-2026) & (k units) Table 166. SAMEA Saphris (Asenapine) Sales by Type (2027-2032) & (k units) Table 167. SAMEA Saphris (Asenapine) Sales Price by Type (2021-2026) & (US$/unit) Table 168. SAMEA Saphris (Asenapine) Sales Price by Type (2027-2032) & (US$/unit) Table 169. SAMEA Saphris (Asenapine) Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Saphris (Asenapine) Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Saphris (Asenapine) Sales by Application (2021-2026) & (k units) Table 172. SAMEA Saphris (Asenapine) Sales by Application (2027-2032) & (k units) Table 173. SAMEA Saphris (Asenapine) Sales Price by Application (2021-2026) & (US$/unit) Table 174. SAMEA Saphris (Asenapine) Sales Price by Application (2027-2032) & (US$/unit) Table 175. SAMEA Saphris (Asenapine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. SAMEA Saphris (Asenapine) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. SAMEA Saphris (Asenapine) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. SAMEA Saphris (Asenapine) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 179. SAMEA Saphris (Asenapine) Sales by Country (2021-2026) & (k units) Table 180. SAMEA Saphris (Asenapine) Sales by Country (2027-2032) & (k units) Table 181. SAMEA Saphris (Asenapine) Sales Price by Country (2021-2026) & (US$/unit) Table 182. SAMEA Saphris (Asenapine) Sales Price by Country (2027-2032) & (US$/unit) Table 183. Brazil Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 184. Argentina Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 185. Chile Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 186. Colombia Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 187. Peru Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 188. Saudi Arabia Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 189. Israel Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 190. UAE Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 191. Turkey Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 192. Iran Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 193. Egypt Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Saphris (Asenapine) Distributors List Table 197. Saphris (Asenapine) Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Saphris (Asenapine) Image Figure 2. Global Saphris (Asenapine) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Saphris (Asenapine) Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5 mg Image Figure 5. 10 mg Image Figure 6. Global Saphris (Asenapine) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Saphris (Asenapine) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Schizophrenia Image Figure 9. Acute Mania Image Figure 10. Others Image Figure 11. Global Saphris (Asenapine) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Saphris (Asenapine) Revenue (2021-2032) & (US$ Million) Figure 13. Global Saphris (Asenapine) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Saphris (Asenapine) Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Saphris (Asenapine) Revenue Market Share by Region (2021-2032) Figure 16. Global Saphris (Asenapine) Sales (2021-2032) & (k units) Figure 17. Global Saphris (Asenapine) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Saphris (Asenapine) Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Saphris (Asenapine) Sales YoY (2021-2032) & (k units) Figure 20. Europe Saphris (Asenapine) Sales YoY (2021-2032) & (k units) Figure 21. China Saphris (Asenapine) Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Saphris (Asenapine) Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Saphris (Asenapine) Sales YoY (2021-2032) & (k units) Figure 24. Global Saphris (Asenapine) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Saphris (Asenapine) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Saphris (Asenapine) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Saphris (Asenapine) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Saphris (Asenapine) Revenue Market Share by Type (2021-2032) Figure 30. Global Saphris (Asenapine) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Saphris (Asenapine) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Saphris (Asenapine) Sales Market Share by Type (2021-2032) Figure 33. Global Saphris (Asenapine) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Saphris (Asenapine) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Saphris (Asenapine) Revenue Market Share by Application (2021-2032) Figure 36. Global Saphris (Asenapine) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Saphris (Asenapine) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Saphris (Asenapine) Sales Market Share by Application (2021-2032) Figure 39. North America Saphris (Asenapine) Revenue Share by Type (2021-2032) Figure 40. North America Saphris (Asenapine) Sales Share by Type (2021-2032) Figure 41. North America Saphris (Asenapine) Revenue Share by Application (2021-2032) Figure 42. North America Saphris (Asenapine) Sales Share by Application (2021-2032) Figure 43. North America Saphris (Asenapine) Revenue Share by Country (2021-2032) Figure 44. North America Saphris (Asenapine) Sales Share by Country (2021-2032) Figure 45. Europe Saphris (Asenapine) Revenue Share by Type (2021-2032) Figure 46. Europe Saphris (Asenapine) Sales Share by Type (2021-2032) Figure 47. Europe Saphris (Asenapine) Revenue Share by Application (2021-2032) Figure 48. Europe Saphris (Asenapine) Sales Share by Application (2021-2032) Figure 49. Europe Saphris (Asenapine) Revenue Share by Country (2021-2032) Figure 50. Europe Saphris (Asenapine) Sales Share by Country (2021-2032) Figure 51. China Saphris (Asenapine) Revenue Share by Type (2021-2032) Figure 52. China Saphris (Asenapine) Sales Share by Type (2021-2032) Figure 53. China Saphris (Asenapine) Revenue Share by Application (2021-2032) Figure 54. China Saphris (Asenapine) Sales Share by Application (2021-2032) Figure 55. Asia Saphris (Asenapine) Revenue Share by Type (2021-2032) Figure 56. Asia Saphris (Asenapine) Sales Share by Type (2021-2032) Figure 57. Asia Saphris (Asenapine) Revenue Share by Application (2021-2032) Figure 58. Asia Saphris (Asenapine) Sales Share by Application (2021-2032) Figure 59. Asia Saphris (Asenapine) Revenue Share by Country (2021-2032) Figure 60. Asia Saphris (Asenapine) Sales Share by Country (2021-2032) Figure 61. SAMEA Saphris (Asenapine) Revenue Share by Type (2021-2032) Figure 62. SAMEA Saphris (Asenapine) Sales Share by Type (2021-2032) Figure 63. SAMEA Saphris (Asenapine) Revenue Share by Application (2021-2032) Figure 64. SAMEA Saphris (Asenapine) Sales Share by Application (2021-2032) Figure 65. SAMEA Saphris (Asenapine) Revenue Share by Country (2021-2032) Figure 66. SAMEA Saphris (Asenapine) Sales Share by Country (2021-2032) Figure 67. Saphris (Asenapine) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Saphris (Asenapine) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg
  • 10 mg
Applications
  • Schizophrenia
  • Acute Mania
  • Others
Companies covered
  • Merck & Co., Inc.
  • Allergan plc (AbbVie Inc.)
  • Actavis Generics (Teva)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Saphris (Asenapine) Market by Type
  3. 1.2.1 Global Saphris (Asenapine) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5 mg
  5. 1.2.3 10 mg
  6. 1.3 Saphris (Asenapine) Market by Application
  7. 1.3.1 Global Saphris (Asenapine) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Schizophrenia
  9. 1.3.3 Acute Mania
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Saphris (Asenapine) Market Dynamics
  1. 2.1 Saphris (Asenapine) Industry Trends
  2. 2.2 Saphris (Asenapine) Industry Drivers
  3. 2.3 Saphris (Asenapine) Industry Opportunities and Challenges
  4. 2.4 Saphris (Asenapine) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Saphris (Asenapine) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Saphris (Asenapine) Revenue by Region
  3. 3.2.1 Global Saphris (Asenapine) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Saphris (Asenapine) Revenue by Region (2021-2026)
  5. 3.2.3 Global Saphris (Asenapine) Revenue by Region (2027-2032)
  6. 3.2.4 Global Saphris (Asenapine) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Saphris (Asenapine) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Saphris (Asenapine) Sales by Region
  9. 3.4.1 Global Saphris (Asenapine) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Saphris (Asenapine) Sales by Region (2021-2026)
  11. 3.4.3 Global Saphris (Asenapine) Sales by Region (2027-2032)
  12. 3.4.4 Global Saphris (Asenapine) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Saphris (Asenapine) Revenue by Manufacturers
  2. 4.1.1 Global Saphris (Asenapine) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Saphris (Asenapine) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Saphris (Asenapine) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Saphris (Asenapine) Sales by Manufacturers
  6. 4.2.1 Global Saphris (Asenapine) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Saphris (Asenapine) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Saphris (Asenapine) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Saphris (Asenapine) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Saphris (Asenapine) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Saphris (Asenapine) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Saphris (Asenapine) Manufacturers, Product Type & Application
  13. 4.7 Global Saphris (Asenapine) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Saphris (Asenapine) Market CR5 and HHI
  16. 4.8.2 2025 Saphris (Asenapine) Tier 1, Tier 2, and Tier 3
5 Saphris (Asenapine) Market by Type
  1. 5.1 Global Saphris (Asenapine) Revenue by Type
  2. 5.1.1 Global Saphris (Asenapine) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Saphris (Asenapine) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Saphris (Asenapine) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Saphris (Asenapine) Sales by Type
  6. 5.2.1 Global Saphris (Asenapine) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Saphris (Asenapine) Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Saphris (Asenapine) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Saphris (Asenapine) Price by Type
6 Saphris (Asenapine) Market by Application
  1. 6.1 Global Saphris (Asenapine) Revenue by Application
  2. 6.1.1 Global Saphris (Asenapine) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Saphris (Asenapine) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Saphris (Asenapine) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Saphris (Asenapine) Sales by Application
  6. 6.2.1 Global Saphris (Asenapine) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Saphris (Asenapine) Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Saphris (Asenapine) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Saphris (Asenapine) Price by Application
7 Company Profiles
  1. 7.1 Merck & Co., Inc.
  2. 7.1.1 Merck & Co., Inc. Company Information
  3. 7.1.2 Merck & Co., Inc. Business Overview
  4. 7.1.3 Merck & Co., Inc. Saphris (Asenapine) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck & Co., Inc. Saphris (Asenapine) Product Portfolio
  6. 7.1.5 Merck & Co., Inc. Recent Developments
  7. 7.2 Allergan plc (AbbVie Inc.)
  8. 7.2.1 Allergan plc (AbbVie Inc.) Company Information
  9. 7.2.2 Allergan plc (AbbVie Inc.) Business Overview
  10. 7.2.3 Allergan plc (AbbVie Inc.) Saphris (Asenapine) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Allergan plc (AbbVie Inc.) Saphris (Asenapine) Product Portfolio
  12. 7.2.5 Allergan plc (AbbVie Inc.) Recent Developments
  13. 7.3 Actavis Generics (Teva)
  14. 7.3.1 Actavis Generics (Teva) Company Information
  15. 7.3.2 Actavis Generics (Teva) Business Overview
  16. 7.3.3 Actavis Generics (Teva) Saphris (Asenapine) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Actavis Generics (Teva) Saphris (Asenapine) Product Portfolio
  18. 7.3.5 Actavis Generics (Teva) Recent Developments
8 North America
  1. 8.1 North America Saphris (Asenapine) Market Size by Type
  2. 8.1.1 North America Saphris (Asenapine) Revenue by Type (2021-2032)
  3. 8.1.2 North America Saphris (Asenapine) Sales by Type (2021-2032)
  4. 8.1.3 North America Saphris (Asenapine) Price by Type (2021-2032)
  5. 8.2 North America Saphris (Asenapine) Market Size by Application
  6. 8.2.1 North America Saphris (Asenapine) Revenue by Application (2021-2032)
  7. 8.2.2 North America Saphris (Asenapine) Sales by Application (2021-2032)
  8. 8.2.3 North America Saphris (Asenapine) Price by Application (2021-2032)
  9. 8.3 North America Saphris (Asenapine) Market Size by Country
  10. 8.3.1 North America Saphris (Asenapine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Saphris (Asenapine) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Saphris (Asenapine) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Saphris (Asenapine) Market Size by Type
  2. 9.1.1 Europe Saphris (Asenapine) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Saphris (Asenapine) Sales by Type (2021-2032)
  4. 9.1.3 Europe Saphris (Asenapine) Price by Type (2021-2032)
  5. 9.2 Europe Saphris (Asenapine) Market Size by Application
  6. 9.2.1 Europe Saphris (Asenapine) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Saphris (Asenapine) Sales by Application (2021-2032)
  8. 9.2.3 Europe Saphris (Asenapine) Price by Application (2021-2032)
  9. 9.3 Europe Saphris (Asenapine) Market Size by Country
  10. 9.3.1 Europe Saphris (Asenapine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Saphris (Asenapine) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Saphris (Asenapine) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Saphris (Asenapine) Market Size by Type
  2. 10.1.1 China Saphris (Asenapine) Revenue by Type (2021-2032)
  3. 10.1.2 China Saphris (Asenapine) Sales by Type (2021-2032)
  4. 10.1.3 China Saphris (Asenapine) Price by Type (2021-2032)
  5. 10.2 China Saphris (Asenapine) Market Size by Application
  6. 10.2.1 China Saphris (Asenapine) Revenue by Application (2021-2032)
  7. 10.2.2 China Saphris (Asenapine) Sales by Application (2021-2032)
  8. 10.2.3 China Saphris (Asenapine) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Saphris (Asenapine) Market Size by Type
  2. 11.1.1 Asia Saphris (Asenapine) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Saphris (Asenapine) Sales by Type (2021-2032)
  4. 11.1.3 Asia Saphris (Asenapine) Price by Type (2021-2032)
  5. 11.2 Asia Saphris (Asenapine) Market Size by Application
  6. 11.2.1 Asia Saphris (Asenapine) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Saphris (Asenapine) Sales by Application (2021-2032)
  8. 11.2.3 Asia Saphris (Asenapine) Price by Application (2021-2032)
  9. 11.3 Asia Saphris (Asenapine) Market Size by Country
  10. 11.3.1 Asia Saphris (Asenapine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Saphris (Asenapine) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Saphris (Asenapine) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Saphris (Asenapine) Market Size by Type
  2. 12.1.1 SAMEA Saphris (Asenapine) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Saphris (Asenapine) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Saphris (Asenapine) Price by Type (2021-2032)
  5. 12.2 SAMEA Saphris (Asenapine) Market Size by Application
  6. 12.2.1 SAMEA Saphris (Asenapine) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Saphris (Asenapine) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Saphris (Asenapine) Price by Application (2021-2032)
  9. 12.3 SAMEA Saphris (Asenapine) Market Size by Country
  10. 12.3.1 SAMEA Saphris (Asenapine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Saphris (Asenapine) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Saphris (Asenapine) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Saphris (Asenapine) Value Chain Analysis
  2. 13.1.1 Saphris (Asenapine) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Saphris (Asenapine) Production Mode & Process
  6. 13.2 Saphris (Asenapine) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Saphris (Asenapine) Distributors
  9. 13.2.3 Saphris (Asenapine) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst